Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06177743 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

IRIS-Coroflex NEO Cohort

Study acronym: IRIS Coroflex
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 31, 2026 to Dec 31, 2028
    • Study completion date: Dec 31, 2030 to Dec 31, 2032
    • Site details revised at 3 of 11 sites
    v5
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Feb 1, 2025 to Jan 9, 2025
    • Site details revised at 11 of 11 sites
    v4
  3. Start date: Aug 31, 2024 to Feb 1, 2025
    • Study sites: 1 to 11
    • Secondary endpoints: 11 to 10
    v3
  4. Start date: Jan 31, 2024 to Aug 31, 2024v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of this study is to evaluate the effectiveness and safety of Coroflex ISAR NEO stents in comparison to other drug-eluting stents (DES) in real-world practice.
Trial Details
NCT Number NCT06177743
Lead Sponsor Seung-Jung Park
Collaborators: The CardioVascular Research Foundation (CVRF)
Conditions
(from sponsor)		 Coronary Artery Stenosis, Coronary Artery Disease
Related terms Coronary Artery Disease, Coronary Stenosis
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov